Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Power chairs for tots: can training therapists help kids with CP move freely?

NCT ID NCT07220590

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 4 times

Summary

This study tests whether a training program for therapists can help them use powered mobility devices with young children (ages 12-32 months) who have severe cerebral palsy. Therapists will learn how to use the devices during everyday routines at home or in early childhood settings. The study will check if the training is practical and helpful for therapists, families, and children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Powered mobility device (Permobil Explorer Mini) and therapist training program
What this could lead to
If successful, this could help young children with severe cerebral palsy gain more independence and participation in daily activities.
What could go wrong
This is a small, early-stage study with only 24 children, so results may not apply to everyone. The training may not work as well in other settings or with different therapists.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 months and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Children: 1. Diagnosis of cerebral palsy or similar motor impairment 2. Gross Motor Function Classification System (GMFCS) Levels IV-V 3. Age 12 to 32 months at enrollment 4. Enrolled in early intervention services Caregivers: 1. Parent or legal guardian of an enrolled child participant 2. Age 18 years or older 3. English- or Spanish-speaking 4. Able and willing to participate in home-based data collection, including caregiver coaching sessions, completion of surveys, and video-recorded sessions 5. Able to provide informed consent Therapists: 1. Licensed physical therapist or occupational therapist 2. Employed at participating early intervention or early childhood special education settings 3. Provide services to children with cerebral palsy or motor delays 4. No prior powered mobility intervention training required 5. Willing to complete powered mobility implementation training and participate in study assessments Exclusion Criteria: 1. Inability or unwillingness to provide informed consent 2. Inability to complete required study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Assistive technology are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Multnomah Early Childhood Program

    RECRUITING

    Portland, Oregon, 97230, United States

  • Northwest Regional Education Service District

    RECRUITING

    Hillsboro, Oregon, 97124, United States

  • Oregon Health & Science University

    ACTIVE_NOT_RECRUITING

    Portland, Oregon, 97239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.